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ABSTRACT
Objective: The objective of this study was to evaluate the applicability of a modified version of the Saint George's
Respiratory Questionnaire. The version evaluated elicits “agree" and “do not agree", rather than “yes" and “no",
responses. The intention is to facilitate the comprehension of double-negative questions and to promote better recollection
of symptoms by patients by shortening their symptom histories from 12 months to 3 months. Methods: A total of 30
clinically stable patients with chronic obstructive pulmonary disease were evaluated. The Saint George's Respiratory
Questionnaire and the modified version of the same were administered 15 days apart. Results: All of the patients
presented health-related alterations in their quality of life. Comparing mean scores between the two questionnaires, the
greatest difference was seen in the Symptoms domain. No significant differences were found in any of the remaining
domains or in the total scores. In a subsequent analysis, significant correlations between the two questionnaires were
found in all domains: Symptoms (r = 0.71; p < 0.001); Activity (r = 0.75; p < 0.001); Impact (r = 0.73; p < 0.001) and
Total (r = 0.86; p < 0.001). Conclusion: The modified version of the Saint George's Respiratory Questionnaire is as
effective as the original in gauging quality of life. However, various symptoms recollection time frames should be
investigated in order to determine which would be the best time frame to employ in the analysis.
Keywords: Pulmonary disease, chronic obstructive; Quality of life; Reproducibility of results; Cross-cultural comparison;
Questionnaires
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INTRODUCTION
The chronic symptoms of the chronic obstructive
pulmonary disease (COPD) - dyspnea, wheezing,
cough, expectoration and exercise intolerance - are
accompanied by anxiety and depression and are the
principal factors responsible for altering the
relationship between health and quality of life.(1)
However, it is known that the severity of symptoms
is not always directly related to the degree of airflow
limitation or to the level of oxygenation at rest, which
is why there has been increasing interest in the study
of the quality of life in patients with COPD.(1)
The determination of quality of life can be
defined as the formalized and standardized
quantification of the impact of the disease on daily
life activities and of the well-being of the
patient.(2)The importance of standardized quality of
life questionnaires is implicit in this concept, since
they allow the objective comparison of the impact
of interventions used in COPD through scores with
numerical (absolute or percentage) expressions.
It is recommended that appropriately developed
quality of life questionnaires be used. The
measurement properties of such questionnaires
should be those duly documented in the specific
literature, including the following: responsiveness
or capacity to detect changes due to interventions;
discriminatory power or capacity to classify patients
with different levels of quality of life; normality value
score; clinically important minimum difference; and
correlations with other measurements traditionally
used in clinical practice.(3) The content of each
questionnaire should also be adapted to the
language and culture of the country in which it will
be used so that the results obtained with the
adapted version will reflect the objectives determined
by each questionnaire author at the time of the
development of the questionnaires in their countries
of origin.(4) This process is called validation, and
aims to maintain the measurement properties
established at the time these questionnaires were
outlined.
The Saint George's Respiratory Questionnaire
(SGRQ) was validated for Brazil in 2000(5) and is
specific for obstructive diseases. However, it has
also been used to evaluate the quality of life in
patients with restrictive pulmonary diseases.(6-7)
During the process of developing the Portuguese
version of the SGRQ (the original was written in
British English), some obstacles to the coherent
construction of some statements and response
alternatives were encountered, mainly regarding
double-negative questions, a common grammar
construction in the English language that could
be difficult for Brazilians to understand.(5) In
clinical practice, the double-negative alternatives
could contribute to make it difficult for some
patients to understand the SGRQ contents. In the
validation process of the Spanish version of the
SGRQ, this cultural limitation was also noted, and
the authors opted for a less conservative validation
and developed a version without the double-
negative phrases.(8)
A new SGRQ version was created for the present
study, eliciting “I agree" and “I disagree", rather
than “yes" and “no", responses, with the intention
of facilitating the comprehension of the content
of the questions (mainly of the double-negative
ones) by the patients. In addition, the period of
recollection of symptoms was shortened from
twelve months (in the original version) to three
months (part 1, questions 1 through 8), in order
to focus on a shorter evaluation period, which is
more appropriate for evaluating some interventions
that yield results more rapidly.(9)
This study was conducted to determine whether
the modified version of the SGRQ (mSGRQ),
employing "I agree" and "I disagree" responses,
maintains the same measurement properties of the
original SGRQ, which has already been validated for
use in Brazil.
METHODS
A convenience sample comprising 30 patients
with COPD was recruited from the COPD Outpatient
Clinic of the Pulmonary Rehabilitation Center of
the Federal University of São Paulo between
January and September of 2002. The following
inclusion criteria were used: a diagnosis of COPD
in accordance with the guidelines established in
the II Brazilian Consensus on COPD(3); clinical
stability during the study and up to 30 days before
the beginning of the evaluations, defined by
determining the clinical stability and adherence to
the current treatment by means of a standardized
questionnaire of symptoms; variation of ± = 10%
of the forced expiratory volume in one second
between visits; variation of ± = 2% in oxygen
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saturation measured through digital pulse oximetry
between visits. Patients scoring < 25 on the
Minimental questionnaire,(10) which measures
cognitive capacity, were excluded, as were those
who presented other concomitant pulmonary
diseases or comorbidities (severe or uncontrolled),
as well as those who opted to discontinue their
participation in the study.
The patients were evaluated during two visits to
the outpatient clinic, fifteen days apart. A two-day
variation (before or after the scheduled visit) was
tolerated for re-evaluation. The following evaluations
were applied during each visit: spirometry (Koko
PFT System), according to the standards of the
Brazilian Society of Pulmonology and Phthisiology;
pulse oximetry (Healthdyne Technologies - model
920m), with the patient breathing room air and at
rest; standard clinical stability questionnaire;
Minimental questionnaire for the evaluation of
cognitive capacity. The body mass index (BMI) was
obtained by calculating the ratio between weight
(kg) and height (m2). This index was used in the
nutritional diagnosis. Values under 22 kg/m2
indicated malnutrition, values between 22 and 27
kg/m2 indicated healthy physical condition, and
values above 27 kg/m2 indicated overweight
status.(11)
One of the following versions of the SGRQ was
administered during each visit: the original, previously
validated Portuguese version (SGRQ), containing "yes"
and "no" responses and the modified version (mSGRQ),
which contains the "I agree" and "I disagree"
alternatives (Annex 1). One version was used in the
first visit and the other was used in the subsequent
visit. The order of application was randomized so
that neither the patient nor the interviewer had any
option. The questionnaires were applied in a quiet
environment, in isolation, and the patient answered
the questions without interference. For illiterate
patients, the interviewer read the questions and
answer alternatives aloud, verbatim (without
explanations). The application of both versions of
the questionnaires was timed.
Written informed consent was obtained from
all patients. The protocol was approved by the
ethics and research committee of the university.
The variables were expressed as mean ± standard
deviation. All continuous variables were analyzed
in order to check the distribution of normality
according to the Kolmogorov-Smirnov test.
Nonparametric tests were used for the variables with
normal distribution. The 95% confidence interval
was calculated to evaluate the mean differences
between the two versions of the questionnaire. The
Wilcoxon test was used to compare two means from
variables with normal distribution. Spearman
correlation coefficient was used to measure the
correlation between two minimally ordinal variables.
The level of statistical significance adopted was 5%.
RESULTS
A total of 36 patients with COPD were evaluated
for inclusion in the study protocol. Of those, 6
patients were excluded: 3 due to exacerbation of
the disease, 2 because they did not return for the
second visit and 1 for presenting a score of < 24
score on the Minimental questionnaire, resulting in
a sample comprised of 30 patients who completed
the study.
Of the 30 patients with COPD, 10 (33.3%) were
female. Mean age was 64.3 ± 7.5 years old. The
BMI ranged from 16 to 33.6 kg/m2 (mean, 25.6 ±
4.1 kg/m2), and 3 patients (10%) were considered
malnourished (BMI < 22 kg/m2), 13 (43.3%) were
considered healthy (BMI between 22 and 27 kg/
m2), and 14 patients (46.6%) were considered
obese (BMI > 27 kg/m2). All of the patients were
former smokers and presented a mean 58.6 ± 38.4
pack-years of exposure to tobacco.
Patient cognition was evaluated using the
Minimental questionnaire, and the minimum score
required for inclusion was 25 points. All but 2 (6.6%)
of the patients scored above 25, and those 2 both
scored exactly 25. The mean Minimental score was
28 ± 1.6 points. There were 5 patients who did not
know how to read (16.6%), and the questionnaires
were read to them by the study interviewers.
Throughout the study, all 30 patients consistently
met the criteria for clinical stability, as assessed using
the symptoms questionnaire and analyzing spirometry
and pulse oximetry measurements (Table 1).
Drug therapy remained unaltered for all the
patients during the 15-day interval between the
applications of the questionnaires.
Regarding the severity of COPD, according to
the classification of the Brazilian Society of
Pulmonology and Phthisiology, 3 patients (10%)
were classified as grade I (mild), 11 (37%) as grade
II (moderate), 13 (43%) as grade III (severe) and 3
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(10%) as grade IV (very severe). Only 2 patients
presented = 88% oxygen saturation by pulse
oximetry, at rest and on room air, and were classified
as hypoxic.
The mean and standard deviation values for
score and mean response time on the two SGRQ
versions are expressed in percentages and are
displayed in Table 2. Response times ranged from
9'10" to 24'10" for the original version of the SGRQ,
and from 9'20" to 30'20" for the mSGRQ.
The entire sample studied presented some
health status alteration (normal values are lower
than 10%).
Spearman's correlation coefficient (r) was used
to evaluate the strength of the correlation between
the two questionnaires, since it was assumed that
the two questionnaires would represent different
evaluations. All of the domains, as well as the
overall score, presented significant correlations:
Symptoms (r = 0.71, p < 0.001); Activity (r = 0.75,
p < 0.001); Impact (r = 0.73, p < 0.001); and Total
(r = 0.86, p < 0.001). The dispersion of the total
score between the SGRQ and the mSGRQ can be
seen in Figure 1.
DISCUSSION
The mSGRQ presents questions on symptoms
recollection over a three-month period (rather than
a twelve-month period as in the original version
previously validated for use in Brazil)(5) and offers
“I agree" and “I disagree" response alternatives to
facilitate the comprehension of the double-negative
questions in the original version. In the sample
studied, which comprised patients with moderate
or severe COPD, the mSGRQ presented quality of
life measurement properties that were similar to
those presented by the SGRQ. The correlations
TABLE 1
Characteristics of pulmonary function and arterial oxygen
saturation by pulse oximetry of patients with chronic
obstructive pulmonary disease who completed the Saint
George's Respiratory Questionnaire in the "yes"/"no", and
"I agree"/"I disagree" versions administered fifteen days
apart (clinical and functional stability)
 
Variable     First Visit    Second Visit     p
SpO2 (% )  93.7 ±  2.7 93.6 ±  2.2 0.9
FEV1 (%) 51.8 ± 20.3 51.1 ± 20.8 0.48
FVC (%) 83.0 ± 20.3 80.1 ± 18.0 0.09
FEV1 /FVC 12.4 ± 12.4 12.5 ± 12.5 0.31
SpO2: arterial oxygen saturation by pulse oximetry; FEV1:
forced expiratory volume in one second; FVC: forced vital
capacity.
TABLE 2
Scores and score response times on the two versions of the Saint George's Respiratory Questionnaire 
Domains and Mean ± SD Mean differences
response time           SGRQ               mSGRQ        SGRQ - mSGRQ          95% CI         p
Symptoms (%) 53.9 ± 20.1 44.1 ± 21.2 9.8 ± 15.86 4.4 -  16.4 0.02
Activities (%) 59.2 ± 19.1 60.7 ± 21.6 -1.4 ± 12.47 -6.3 - 3.4 0.83
Impact (%) 39.5 ± 20.0 34.5 ± 17.7 5.0 ± 13.72 -0.4 - 10.2 0.17
Total (%) 47.9 ± 16.7 44.0 ± 16.9 3.85 ± 9.6 0.2 - 7.6 0.18
Time (min and sec)    14’84" ± 3’51"           13’24" ±  4’10"            - - 0.41
SD: standard deviation; SGRQ: Saint George's Respiratory Questionnaire; mSGRQ: modified Saint George's Respiratory
Questionnaire; 95% CI: 95% confidence interval
Figure 1 - Dispersion of the total score between the two
SGRQ questionnaires in the 30 patients with COPD
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between the two questionnaires in the Symptoms,
Activity and Impact domains, as well as in the
overall score, were statistically significant and
similar to the reproducibility values found in the
original validation study (which evaluated identical
versions administered during two different visits).(5)
This result can be considered noteworthy because
this study applied the same method of patient
recruiting and analysis used in the original study
that validated the SGRQ for use in Brazil. However,
since this study was carried out in the same center,
there might be some limitation regarding the
applicability of the results and conclusions in other
populations. The application time of the two
versions was similar, which indirectly shows that
the understanding of the statements was also
similar. Therefore, this study might imply that the
mSGRQ should be the version of choice, both in
the research environment and in health care
facilities that use this questionnaire, since the
quantification of quality of life has also been used
outside the academic environment.
The sample of patients had good cognition, as
per the Minimental questionnaires. Since the
patients had been referred to a tertiary care center,
they presented with moderate or severe COPD and
altered quality of life, as evidenced by the
descriptive pulmonary function and quality of life
data. It was not possible to evaluate, in isolation,
the correlations between the two questionnaires
applied to illiterate patients since the sample was
not powerful enough (only 5 patients). This aspect
has also been analyzed in the previous validations
of specif ic quest ionnaires for obstructive
pulmonary disease in Brazil.(5,12)
In the present study, the mean overall scores,
as well as the scores for the Activity and Impact
domains, were not statistically significant between
the two SGRQ versions. Since one of the criteria
used is the minimum clinically significant
difference, which is four points in the case of the
SGRQ,(13) we calculated the 95% confidence interval
for the difference between the mean scores of each
SGRQ version. The 95% confidence interval
surpassed the threshold of clinical difference in
the Total score, Activity domain score and Impact
domain score, revealing the high variability of these
questionnaires. It is important to mention that no
intervention was performed between the two
evaluations. We recommend that validation studies
be used to calculate the minimum sample number
necessary when making this kind of evaluation. It
is not possible to suggest a minimum number
needed to detect the four-point difference in this
study since the two versions were considered
different. The modification in the types of response,
using “I agree" and “I disagree" rather than “yes"
and “no", did not alter the quality of life
measurement properties.
The criteria for COPD clinical stability usually
involve spirometry findings and clinical history,(14)
both of which were evaluated in this study. A period
of one month without exacerbations prior to the
study period was used as an inclusion criterion in
order to rule out any consequent interference with
the scores evaluated.(15) It is known that other
measurements, such as inspiratory capacity,
correlate more strongly with COPD symptoms,
mainly dyspnea, which is one of the most important
determinants of altered quality of life.(16) It is also
well known that COPD symptoms are the greatest
determinants of altered quality of life and, since
patients with mild COPD are oligosymptomatic,
often constitute the main motivation for patients
to seek treatment at the health care facility.(17)
Assuming clinical stability, however, we noticed that
there was significant variability in the Symptoms
domain and that the 95% confidence interval of
the mean score difference between the two versions
was above four points in percentage, leading us
to the conclusion that the two questionnaires
evaluated this aspect of quality of life in distinct
ways. Since the recollection time was shortened
from twelve months to three months from one
version to the other, we concluded that this part
of the questionnaire has undergone a real change
from the statistical and clinical points of view. It is
therefore recommended that researchers choose
between the three- and the twelve-month
recollection period on a case-by-case basis,
depending on the objective of their study.
We concluded that the mSGRQ has quality of
life measurement properties for use in patients
with moderate and severe COPD that are similar
to those possessed by the original Brazilian SGRQ.
However, researchers should choose the best time
frame for symptoms recollection to be used in
each study.
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Anexx 1 - The Saint George's Respiratory Questionnaire modified to three months (mSGRQ)
Before completing the questionnaire:
Put an "x" in the box next to the response that better describes your state of health:
Very good (  )1  Good (  )2  Moderate (  )3  Poor (  )4  Very Poor (  )5
PART 1
Among the alternatives below, check the one that best identifies your respiratory problems in the last 3
months. Note: Mark only one alternative for each question.
  Over the last 3 months: most days several days     a few days  only when I    nunca
per week        per month  had a respiratory
 1. I coughed
  2. I was congested
  3. I had shortness of breath
  4. I had wheezing episodes
 5. Over the last 3 months, how many attacks of severe respiratory problems have you had?
  More than   3 3 2 1 None
 6. How long did the worst attack last? (Go to question 7 if you did not have any severe attacks)
  1 week or more 3 or more days 1 or 2 days  less than 1 day
  7. Over the last 3 months, in a typical week, how many good days (with few respiratory problems) did you  have?
   None   1 or 2 days 3 or 4 days almost all days 1 all days
8. If you experience wheezing, is it worse in the morning?
  No  0 Yes   1
PART 2
Section 1
Mark only 1 alternative to describe your respiratory disease:
  It is my greatest it causes me it causes me it does not cause
  me problem a lot of problems            a few problems any problem
If you have ever held a paying job, mark one of the alternatives: (go to section 2 if you don't work)
 My respiratory disease forced me to stop working
 My respiratory disease interferes (or has interfered) with my regular job or has forced me to change jobs
 My respiratory disease does not affect (or has not affected ) my work
Section 2
The answers below refer to activities that have typically caused you shortness of breath in the last few days.
Mark each alternative below with an "x", indicating the response "I agree" or "I disagree", according to your
case:
 Sitting or lying down I agree I disagree
Taking a shower or getting dressed I agree I disagree
Walking around inside the house I agree I disagree
Walking on level ground I agree I disagree
Climbing up a flight of stairs I agree I disagree
Going up steep slopes I agree I disagree
Doing sports or playing games that involve physical exertion I agree I disagree
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Section 3
Here are a few more statements about your cough and shortness of breath in the last few days. Mark each
option below with an "x", selecting the response "I agree" or "I disagree", according to your case:
  My cough causes me pain I agree I disagree
  My cough makes me feel tired I agree I disagree
  I have shortness of breath when I speak I agree I disagree
  I have shortness of breath when I lean forward I agree I disagree
  My cough or shortness of breath disturbs my sleep I agree I disagree
  I get exhausted easily I agree I disagree
 Section 4
Here are some statements about other effects caused by your respiratory disease in the last few days. Mark
each option below with an "x", selecting the response "I agree" or "I disagree", according to your case:
  My cough or shortness of breath embarrasses me in public I agree I disagree
  My respiratory disease is inconvenient for my family,
  friends or neighbors I agree I disagree
  I am afraid, or even panic, when I cannot breathe I agree I disagree
  I feel that my respiratory disease is out of my control I agree I disagree
  I do not expect any improvement in my respiratory disease I agree I disagree
  My disease has physically debilitated me, which makes me
  need help from others I agree I disagree
  Doing exercises is risky for me I agree I disagree
  All I do seems to demand great effort I agree I disagree
Section 5
Here are some statements about your medication. If you are not taking any medication, go to section 6. Mark
each alternative below with an "x", selecting the response "I agree" or "I disagree", according to your case:
  my medication is not helping me much I agree I disagree
  I am embarrassed to take medication in public I agree I disagree
  my medication causes unpleasant side effects I agree I disagree
  my medication interferes considerably with my
  day-to-day activities I agree I disagree
Section 6
The next items refer to the activities that can be affected by your respiratory disease.
Mark each alternative below with an "x", selecting the response "I agree" if at least one part of the sentence
is applicable to your case. Otherwise, select "I disagree".
   It takes me a long time to bathe or get dressed I agree I disagree
  It takes me a long time (or I am unable) to take a shower or a bath I agree I disagree
  I walk slower than do other people or I have to stop for a rest I agree I disagree
  It takes me a long time to perform tasks such as
  household chores, or I have to stop for a rest I agree I disagree
  When I go up a flight of stairs, I do it very slowly or I have to stop and rest I agree I disagree
  If I am in a hurry or walk faster, I have to stop and rest or go more slowly I agree I disagree
  Because of my respiratory disease, I have difficulty in performing activities such
  as: going up steep slopes, carrying objects while climbing stairs, dancing, etc. I agree I disagree
  Because of my respiratory disease I have difficulty in activities such as: lifting
  heavy weights, jogging, walking fast (8 km/h) or swimming I agree I disagree
  Because of my respiratory disease, I have difficulty in activities such as:
  heavy manual labor, running, swimming fast or engaging in very tiring sports I agree I disagree
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Section 7
We would like to know how your respiratory disease typically affects your day-to-day activities.
Mark the response "I agree" or "I disagree" with an "x":
(Remember that "I agree" is only applicable to your case when you are unable to do this activity due to your
respiratory disease)
  I am not able to do sports or play games that involve physical exertion I agree I disagree
  I am not able to go out of the house to have fun I agree I disagree
  I am not able to go out to do my shopping I agree I disagree
  I am not able to do household chores I agree I disagree
  I am not able to get out of bed or out of a chair I agree I disagree
The next list describes a series of other activities that your respiratory problem might prevent you from doing.
(You do not need to select any of the activities, our intention is merely to remind you of the activities that
might be affected by your shortness of breath).
  Go out for a walk or walk your dog
  Do household chores or gardening
  Have sexual intercourse
  Go to church, bars or entertainment locales
  Go out in bad weather or stay in places where there is cigarette smoke
  Visit family and friends or play with the kids
  Please indicate any other important activity that your respiratory disease might prevent you from doing.
  ____________________________________________________________________
Mark with an "x" only the response that best defines the way in which you are affected by your respiratory
disease:
  It does not prevent me from doing any of the things I would like to do (0)
  It prevents me from doing one or two things that I would like to do (1)
  It prevents me from doing most of the things that I would like to do (2)
  It prevents me from doing everything that I would like to do (3)
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